177 related articles for article (PubMed ID: 23744056)
1. Impact of Hey2 and COUP-TFII on genes involved in arteriovenous differentiation in primary human arterial and venous endothelial cells.
Korten S; Brunssen C; Poitz DM; Großklaus S; Brux M; Schnittler HJ; Strasser RH; Bornstein SR; Morawietz H; Goettsch W
Basic Res Cardiol; 2013 Jul; 108(4):362. PubMed ID: 23744056
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate.
Diez H; Fischer A; Winkler A; Hu CJ; Hatzopoulos AK; Breier G; Gessler M
Exp Cell Res; 2007 Jan; 313(1):1-9. PubMed ID: 17045587
[TBL] [Abstract][Full Text] [Related]
3. COUP-TFII is a major regulator of cell cycle and Notch signaling pathways.
Chen X; Qin J; Cheng CM; Tsai MJ; Tsai SY
Mol Endocrinol; 2012 Aug; 26(8):1268-77. PubMed ID: 22734039
[TBL] [Abstract][Full Text] [Related]
4. Venous Endothelial Marker COUP-TFII Regulates the Distinct Pathologic Potentials of Adult Arteries and Veins.
Cui X; Lu YW; Lee V; Kim D; Dorsey T; Wang Q; Lee Y; Vincent P; Schwarz J; Dai G
Sci Rep; 2015 Nov; 5():16193. PubMed ID: 26537113
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity.
You LR; Lin FJ; Lee CT; DeMayo FJ; Tsai MJ; Tsai SY
Nature; 2005 May; 435(7038):98-104. PubMed ID: 15875024
[TBL] [Abstract][Full Text] [Related]
6. COUP-TFII is regulated by high glucose in endothelial cells.
Brunssen C; Korten S; Brux M; Seifert S; Roesler J; Bornstein SR; Morawietz H; Goettsch W
Horm Metab Res; 2010 Feb; 42(2):81-7. PubMed ID: 19862665
[TBL] [Abstract][Full Text] [Related]
7. Arterial-venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation.
Zhang G; Zhou J; Fan Q; Zheng Z; Zhang F; Liu X; Hu S
FEBS Lett; 2008 Aug; 582(19):2957-64. PubMed ID: 18671974
[TBL] [Abstract][Full Text] [Related]
8. COUP-TFII orchestrates venous and lymphatic endothelial identity by homo- or hetero-dimerisation with PROX1.
Aranguren XL; Beerens M; Coppiello G; Wiese C; Vandersmissen I; Lo Nigro A; Verfaillie CM; Gessler M; Luttun A
J Cell Sci; 2013 Mar; 126(Pt 5):1164-75. PubMed ID: 23345397
[TBL] [Abstract][Full Text] [Related]
9. An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells.
Kang J; Yoo J; Lee S; Tang W; Aguilar B; Ramu S; Choi I; Otu HH; Shin JW; Dotto GP; Koh CJ; Detmar M; Hong YK
Blood; 2010 Jul; 116(1):140-50. PubMed ID: 20351309
[TBL] [Abstract][Full Text] [Related]
10. COUP-TFII switches responses of venous endothelium to atherosclerotic factors through controlling the profile of various inherent genes expression.
Wu X; Zou Y; Liang Y; Zhou Q; Gong H; Sun A; Yuan L; Wang K; Ge J
J Cell Biochem; 2011 Jan; 112(1):256-64. PubMed ID: 21069739
[TBL] [Abstract][Full Text] [Related]
11. Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells.
Hayashi H; Kume T
PLoS One; 2008 Jun; 3(6):e2401. PubMed ID: 18545664
[TBL] [Abstract][Full Text] [Related]
12. DNMT3A inhibits E2F1-induced arterial marker expression and impairs angiogenesis in human umbilical artery endothelial cells.
Su K; Lin N; Xie S; Han Y; Yang Z; Zhang H; He H; Zhou SA; Ma W; Zhang T; Wang N
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1236-1246. PubMed ID: 33079978
[TBL] [Abstract][Full Text] [Related]
13. Arterial-venous specification during development.
Swift MR; Weinstein BM
Circ Res; 2009 Mar; 104(5):576-88. PubMed ID: 19286613
[TBL] [Abstract][Full Text] [Related]
14. Specification of arterial, venous, and lymphatic endothelial cells during embryonic development.
Kume T
Histol Histopathol; 2010 May; 25(5):637-46. PubMed ID: 20238301
[TBL] [Abstract][Full Text] [Related]
15. Dll4-selective Notch signaling induces ephrinB2 gene expression in endothelial cells.
Iso T; Maeno T; Oike Y; Yamazaki M; Doi H; Arai M; Kurabayashi M
Biochem Biophys Res Commun; 2006 Mar; 341(3):708-14. PubMed ID: 16430858
[TBL] [Abstract][Full Text] [Related]
16. COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction.
Yamazaki T; Yoshimatsu Y; Morishita Y; Miyazono K; Watabe T
Genes Cells; 2009 Mar; 14(3):425-34. PubMed ID: 19210544
[TBL] [Abstract][Full Text] [Related]
17. BRG1 promotes COUP-TFII expression and venous specification during embryonic vascular development.
Davis RB; Curtis CD; Griffin CT
Development; 2013 Mar; 140(6):1272-81. PubMed ID: 23406903
[TBL] [Abstract][Full Text] [Related]
18. Functional arterial and venous fate is determined by graded VEGF signaling and notch status during embryonic stem cell differentiation.
Lanner F; Sohl M; Farnebo F
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):487-93. PubMed ID: 17185616
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling.
Qin J; Chen X; Yu-Lee LY; Tsai MJ; Tsai SY
Cancer Res; 2010 Nov; 70(21):8812-21. PubMed ID: 20978203
[TBL] [Abstract][Full Text] [Related]
20. The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development.
Seo S; Fujita H; Nakano A; Kang M; Duarte A; Kume T
Dev Biol; 2006 Jun; 294(2):458-70. PubMed ID: 16678147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
